The hippo pathway effectors TAZ and YAP in development, homeostasis and disease

Development (Cambridge)

Volumn 141, Issue 8, 2014, Pages 1614-1626

  Varelas, Xaralabos ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hippo pathway; Mechanosensing; Organ patterning; Pre implantation development; Stem cells

Indexed keywords

ADAPTOR PROTEIN; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; HIPPO KINASE; MICRORNA; PHOSPHOTRANSFERASE; REGULATOR PROTEIN; TAZ PROTEIN; UNCLASSIFIED DRUG; YAP PROTEIN;

ACUTE PANCREATITIS; APOPTOSIS; CAENORHABDITIS ELEGANS; CELL ADHESION; CELL FATE; CELL MOTION; CELL POLARITY; CELL PROLIFERATION; DEVELOPMENT; DISEASES; DROSOPHILA MELANOGASTER; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; EPIDERMIS; GENETIC CONSERVATION; HEART DEVELOPMENT; HEART SIZE; HOMEOSTASIS; HUMAN; INTESTINE; KIDNEY; KIDNEY DEVELOPMENT; KIDNEY POLYCYSTIC DISEASE; LIVER; LIVER CELL CARCINOMA; LIVER REGENERATION; MORPHOGENESIS; NERVOUS SYSTEM; NONHUMAN; ORGAN SIZE; ORGANOGENESIS; PANCREAS; PREIMPLANTATION EMBRYO; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; SACCHAROMYCES CEREVISIAE; SALIVARY GLAND; SIGNAL TRANSDUCTION; SJOEGREN SYNDROME; SKIN; SQUAMOUS CELL CARCINOMA; STEM CELL; TISSUE GROWTH; TISSUE REGENERATION; TISSUE REPAIR; TRANSCRIPTION REGULATION; VERTEBRATE;

HIPPO PATHWAY; MECHANOSENSING; ORGAN PATTERNING; PRE-IMPLANTATION DEVELOPMENT; STEM CELLS;

ANIMALS; DISEASE; HOMEOSTASIS; HUMANS; SIGNAL TRANSDUCTION; STEM CELLS; TRANSCRIPTION FACTORS; VERTEBRATES;

EID: 84898715615     PISSN: 09501991     EISSN: 14779129     Source Type: Journal    
DOI: 10.1242/dev.102376     Document Type: Review

References (154)

1. Abercrombie, M. (1979). Contact inhibition and malignancy. Nature 281, 259-262.
2. Alarcon, C., Zaromytidou, A.-I., Xi, Q., Gao, S., Yu, J., Fujisawa, S., Barlas, A., Miller, A. N., Manova-Todorova, K., Macias, M. J. et al. (2009). Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. Cell 139, 757-769.
3. Anakk, S., Bhosale, M., Schmidt, V. A., Johnson, R. L., Finegold, M. J. and Moore, D. D. (2013). Bile acids activate YAP to promote liver carcinogenesis. Cell Rep. 5, 1060-1069.
4. Apte, U., Gkretsi, V., Bowen, W. C., Mars, W. M., Luo, J.-H., Donthamsetty, S., Orr, A., Monga, S. P. S., Wu, C. and Michalopoulos, G. K. (2009). Enhanced liver regeneration following changes induced by hepatocyte-specific genetic ablation of integrin-linked kinase. Hepatology 50, 844-851.
5. Aragona, M., Panciera, T., Manfrin, A., Giulitti, S., Michielin, F., Elvassore, N., Dupont, S. and Piccolo, S. (2013). A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors. Cell 154, 1047-1059.
6. Azzolin, L., Zanconato, F., Bresolin, S., Forcato, M., Basso, G., Bicciato, S., Cordenonsi, M. and Piccolo, S. (2012). Role of TAZ as mediator of Wnt signaling. Cell 151, 1443-1456.
7. Bai, H., Zhang, N., Xu, Y., Chen, Q., Khan, M., Potter, J. J., Nayar, S. K., Cornish, T., Alpini, G., Bronk, S. et al. (2012). Yes-associated protein regulates the hepatic response after bile duct ligation. Hepatology 56, 1097-1107.
8. Barry, E. R., Morikawa, T., Butler, B. L., Shrestha, K., de la Rosa, R., Yan, K. S., Fuchs, C. S., Magness, S. T., Smits, R., Ogino, S. et al. (2013). Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature 493, 106-110.
9. Basu, S., Totty, N. F., Irwin, M. S., Sudol, M. and Downward, J. (2003). Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol. Cell 11, 11-23.
10. Beyer, T. A., Narimatsu, M., Weiss, A., David, L. and Wrana, J. L. (2013a). The TGFbeta superfamily in stem cell biology and early mammalian embryonic development. Biochim. Biophys. Acta 1830, 2268-2279.
11. Beyer, T. A., Weiss, A., Khomchuk, Y., Huang, K., Ogunjimi, A. A., Varelas, X. and Wrana, J. L. (2013b). Switch enhancers interpret TGF-β and hippo signaling to control cell fate in human embryonic stem cells. Cell Rep. 5, 1611-1624.
12. Bjarnadottir, T. K., Gloriam, D. E., Hellstrand, S. H., Kristiansson, H., Fredriksson, R. and Schioth, H. B. (2006). Comprehensive repertoire and phylogenetic analysis of the G protein-coupled receptors in human and mouse. Genomics 88, 263-273.
13. Bosl, W.J. and Li, R. (2005). Mitotic-exit controlasan evolved complex system. Cell 121, 325-333.
14. Cai, J., Zhang, N., Zheng, Y., de Wilde, R. F., Maitra, A. and Pan, D. (2010). The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev. 24, 2383-2388.
15. Calvo, F., Ege, N., Grande-Garcia, A., Hooper, S., Jenkins, R. P., Chaudhry, S.I., Harrington, K., Williamson, P., Moeendarbary, E., Charras, G. et al. (2013). Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nat. Cell Biol. 15, 637-646.
16. Camargo, F. D., Gokhale, S., Johnnidis, J. B., Fu, D., Bell, G. W., Jaenisch, R. and Brummelkamp, T. R. (2007). YAP1 increases organ size and expands undifferentiated progenitor cells. Curr. Biol. 17, 2054-2060.
17. Cao, X., Pfaff, S. L. and Gage, F. H. (2008). YAP regulates neural progenitor cell number via the TEA domain transcription factor. Genes Dev. 22, 3320-3334.
18. Cappello, S., Gray, M. J., Badouel, C., Lange, S., Einsiedler, M., Srour, M., Chitayat, D., Hamdan, F.F., Jenkins, Z.A., Morgan, T. et al. (2013). Mutations in genes encoding the cadherin receptor-ligand pair DCHS1 and FAT4 disrupt cerebral cortical development. Nat. Genet. 45, 1300-1308.
19. Chan, S. W., Lim, C. J., Chong, Y. F., Pobbati, A. V., Huang, C. and Hong, W. (2011). Hippo pathway-independent restriction of TAZ and YAP by angiomotin. J. Biol. Chem. 286, 7018-7026.
20. Chaulk, S. G., Lattanzi, V. J., Hiemer, S. E., Fahlman, R. P. and Varelas, X. (2013). The hippo pathway effectors TAZ/YAP regulate dicer expression and miRNA biogenesis through let-7. J. Biol. Chem. 289, 1886-1891.
21. Chen, L., Chan, S. W., Zhang, X., Walsh, M., Lim, C. J., Hong, W. and Song, H. (2010). Structural basis of YAP recognition by TEAD4 in the hippo pathway. Genes Dev. 24, 290-300.
22. Chen, D., Sun, Y., Wei, Y., Zhang, P., Rezaeian, A. H., Teruya-Feldstein, J., Gupta, S., Liang, H., Lin, H.-K., Hung, M.C. et al. (2012). LIFR is abreast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker. Nat. Med. 18, 1511-1517.
23. Chung, C., Kim, T., Kim, M., Kim, M., Song, H., Kim, T.-S., Seo, E., Lee, S.-H., Kim, H., Kim, S. K. et al. (2013). Hippo-Foxa2 signaling pathway plays a role in peripheral lung maturation and surfactant homeostasis. Proc. Natl. Acad. Sci. USA 110, 7732-7737.
24. Cockburn, K. and Rossant, J. (2010). Making the blastocyst: lessons from the mouse. J. Clin. Invest. 120, 995-1003.
25. Cockburn, K., Biechele, S., Garner, J. and Rossant, J. (2013). The Hippo pathway member Nf2 is required for inner cell mass specification. Curr. Biol. 23, 1195-1201.
26. Cordenonsi, M., Zanconato, F., Azzolin, L., Forcato, M., Rosato, A., Frasson, C., Inui, M., Montagner, M., Parenti, A. R., Poletti, A. et al. (2011). The hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell 147, 759-772.
27. Couzens, A. L., Knight, J. D. R., Kean, M. J., Teo, G., Weiss, A., Dunham, W. H., Lin, Z.-Y., Bagshaw, R. D., Sicheri, F., Pawson, T. et al. (2013). Protein interaction network of the Mammalian hippo pathway reveals mechanisms of kinase-phosphatase interactions. Sci. Signal. 6, rs15.
28. Das Thakur, M., Feng, Y., Jagannathan, R., Seppa, M. J., Skeath, J. B. and Longmore, G. D. (2010). Ajuba LIM proteins are negative regulators of the Hippo signaling pathway. Curr. Biol. 20, 657-662.
29. Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A. and Pan, D. (2007). Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130, 1120-1133.
30. Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S. et al. (2011). Role of YAP/TAZ in mechanotransduction. Nature 474, 179-183.
31. Enger, T. B., Samad-Zadeh, A., Bouchie, M. P., Skarstein, K., Galtung, H. K., Mera, T., Walker, J., Menko, A. S., Varelas, X., Faustman, D. L. et al. (2013). The Hippo signaling pathway is required for salivary gland development and its dysregulation is associated with Sjogren's syndrome. Lab. Invest. 93, 1203-1218.
32. Engler, A. J., Sen, S., Sweeney, H. L. and Discher, D. E. (2006). Matrix elasticity directs stem cell lineage specification. Cell 126, 677-689.
33. Fernandez, B. G., Gaspar, P., Bras-Pereira, C., Jezowska, B., Rebelo, S. R. and Janody, F. (2011). Actin-capping protein and the hippo pathway regulate F-actin and tissue growth in Drosophila. Development 138, 2337-2346.
34. Gao, T., Zhou, D., Yang, C., Singh, T., Penzo-Mendez, A., Maddipati, R., Tzatsos, A., Bardeesy, N., Avruch, J. and Stanger, B. Z. (2013). Hippo signaling regulates differentiation and maintenance in the exocrine pancreas. Gastroenterology 144, 1543-1553, 1553 e1541.
35. Gee, S. T., Milgram, S. L., Kramer, K. L., Conlon, F. L. and Moody, S. A. (2011). Yes-associated protein 65 (YAP) expands neural progenitors and regulates Pax3 expression in the neural plate border zone. PLoS ONE 6, e20309.
36. George, N. M., Day, C. E., Boerner, B. P., Johnson, R. L. and Sarvetnick, N. E. (2012). Hippo signaling regulates pancreas development through inactivation of Yap. Mol. Cell. Biol. 32, 5116-5128.
37. von Gise, A., Lin, Z., Schlegelmilch, K., Honor, L. B., Pan, G. M., Buck, J. N., Ma, Q., Ishiwata, T., Zhou, B., Camargo, F. D. et al. (2012). YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy. Proc. Natl. Acad. Sci. USA 109, 2394-2399.
38. Gladden, A. B., Hebert, A. M., Schneeberger, E. E. and McClatchey, A. I. (2010). The NF2 tumor suppressor, Merlin, regulates epidermal development through the establishment of a junctional polarity complex. Dev. Cell 19, 727-739.
39. Gordon, M., El-Kalla, M., Zhao, Y., Fiteih, Y., Law, J., Volodko, N., Mohamed, A., El-Kadi, A. O.S, Liu, L., Odenbach, J. et al. (2013). The tumor suppressor gene, RASSF1A, is essential for protection against inflammation -induced injury. PLoS ONE 8, e75483.
40. Goulev, Y., Fauny, J. D., Gonzalez-Marti, B., Flagiello, D., Silber, J. and Zider, A. (2008). SCALLOPED interacts with YORKIE, the nuclear effector of the hippo tumor-suppressor pathway in Drosophila. Curr. Biol. 18, 435-441.
41. Harvey, K. F., Zhang, X. and Thomas, D. M. (2013). The Hippo pathway and human cancer. Nat. Rev. Cancer 13, 246-257.
42. Hau, J. C., Erdmann, D., Mesrouze, Y., Furet, P., Fontana, P., Zimmermann, C., Schmelzle, T., Hofmann, F. and Chene, P. (2013). The TEAD4-YAP/TAZ protein-protein interaction: expected similarities and unexpected differences. Chembiochem 14, 1218-1225.
43. Heallen, T., Zhang, M., Wang, J., Bonilla-Claudio, M., Klysik, E., Johnson, R. L. and Martin, J. F. (2011). Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 332, 458-461.
44. Heallen, T., Morikawa, Y., Leach, J., Tao, G., Willerson, J. T., Johnson, R. L. and Martin, J. F. (2013). Hippo signaling impedes adult heart regeneration. Development 140, 4683-4690.
45. Hergovich, A., Stegert, M. R., Schmitz, D. and Hemmings, B. A. (2006). NDR kinases regulate essential cell processes from yeast to humans. Nat. Rev. Mol. Cell Biol. 7, 253-264.
46. Hilman, D. and Gat, U. (2011). The evolutionary history of YAP and the hippo/YAP pathway. Mol. Biol. Evol. 28, 2403-2417.
47. Hirate, Y., Hirahara, S., Inoue, K.-i., Suzuki, A., Alarcon, V. B., Akimoto, K., Hirai, T., Hara, T., Adachi, M., Chida, K. et al. (2013). Polarity-dependent distribution of angiomotin localizes Hippo signaling in preimplantation embryos. Curr. Biol. 23, 1181-1194.
48. Home, P., Saha, B., Ray, S., Dutta, D., Gunewardena, S., Yoo, B., Pal, A., Vivian, J. L., Larson, M., Petroff, M. et al. (2012). Altered subcellular localization of transcription factor TEAD4 regulates first mammalian cell lineage commitment. Proc. Natl. Acad. Sci. USA 109, 7362-7367.
49. Hong, J.-H., Hwang, E. S., McManus, M. T., Amsterdam, A., Tian, Y., Kalmukova, R., Mueller, E., Benjamin, T., Spiegelman, B. M., Sharp, P. A. et al. (2005). TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309, 1074-1078.
50. Hossain, Z., Ali, S. M., Ko, H. L., Xu, J., Ng, C. P., Guo, K., Qi, Z., Ponniah, S., Hong, W. and Hunziker, W. (2007). Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1. Proc. Natl. Acad. Sci. USA 104, 1631-1636.
51. Howell, M., Borchers, C. and Milgram, S. L. (2004). Heterogeneous nuclear ribonuclear protein U associates with YAP and regulates its co-activation of Bax transcription. J. Biol. Chem. 279, 26300-26306.
52. Hu, J., Sun, S., Jiang, Q., Sun, S., Wang, W., Gui, Y. and Song, H. (2013). Yes-associated protein (yap) is required for early embryonic development in zebrafish (Danio rerio). Int. J. Biol. Sci. 9, 267-278.
53. Huang, J., Wu, S., Barrera, J., Matthews, K. and Pan, D. (2005). The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP. Cell 122, 421-434.
54. Huang, W., Lv, X., Liu, C., Zha, Z., Zhang, H., Jiang, Y., Xiong, Y., Lei, Q.-Y. and Guan, K. L. (2012). The N-terminal phosphodegron argets TAZ/WWTR1 protein for SCFbeta-TrCP-dependent degradation in response to phosphatidylinositol 3-kinase inhibition. J. Biol. Chem. 287, 26245-26253.
55. Iwasa, H., Maimaiti, S., Kuroyanagi, H., Kawano, S., Inami, K., Timalsina, S., Ikeda, M., Nakagawa, K. and Hata, Y. (2013). Yes-associated protein homolog, YAP-1, is involved in the thermotolerance and aging in the nematode Caenorhabditis elegans. Exp. Cell Res. 319, 931-945.
56. James, M. F., Manchanda, N., Gonzalez-Agosti, C., Hartwig, J. H. and Ramesh, V. (2001). The neurofibromatosis 2 protein product merlin selectively binds F-actin but not G-actin, and stabilizes the filaments through a lateral association. Biochem. J. 356, 377-386.
57. Jang, E. J., Jeong, H., Han, K. H., Kwon, H. M., Hong, J.-H. and Hwang, E. S. (2012). TAZ suppresses NFAT5 activity through tyrosine phosphorylation. Mol. Cell. Biol. 32, 4925-4932.
58. Jia, J., Zhang, W., Wang, B., Trinko, R. and Jiang, J.(2003). The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis. Genes Dev. 17, 2514-2519.
59. Jiang, Q., Liu, D., Gong, Y., Wang, Y., Sun, S., Gui, Y. and Song, H. (2009). yap is required for the development of brain, eyes, and neural crest in zebrafish. Biochem. Biophys. Res. Commun. 384, 114-119.
60. Justice, R. W., Zilian, O., Woods, D. F., Noll, M. and Bryant, P. J. (1995). The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev. 9, 534-546.
61. Kanai, F., Marignani, P. A., Sarbassova, D., Yagi, R., Hall, R. A., Donowitz, M., Hisaminato, A., Fujiwara, T., Ito, Y., Cantley, L. C. et al. (2000). TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J. 19, 6778-6791.
62. Kaneko, K. J. and DePamphilis, M. L. (2013). TEAD4 establishes the energy homeostasis essential for blastocoel formation. Development 140, 3680-3690.
63. Kim, M., Kim, M., Lee, S., Kuninaka, S., Saya, H., Lee, H., Lee, S. and Lim, D.-S. (2013). cAMP/PKA signalling reinforces the LATS-YAP pathway to fully suppress YAP in response to actin cytoskeletal changes. EMBO J. 32, 1543-1555.
64. Koontz, L. M., Liu-Chittenden, Y., Yin, F., Zheng, Y., Yu, J., Huang, B., Chen, Q., Wu, S. and Pan, D. (2013). The Hippo effector Yorkie controls normal tissue growth by antagonizing scalloped-mediated default repression. Dev. Cell 25, 388-401.
65. Kwon, Y., Vinayagam, A., Sun, X., Dephoure, N., Gygi, S. P., Hong, P. and Perrimon, N. (2013). The Hippo signaling pathway interactome. Science 342, 737-740.
66. Lamar, J. M., Stern, P., Liu, H., Schindler, J. W., Jiang, Z.-G. and Hynes, R. O. (2012). The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain. Proc. Natl. Acad. Sci. USA 109, E2441-E2450.
67. Lavado, A., He, Y., Pare, J., Neale, G., Olson, E. N., Giovannini, M. and Cao, X. (2013). Tumor suppressor Nf2 limits expansion of the neural progenitor pool by inhibiting Yap/Taz transcriptional coactivators. Development 140, 3323-3334.
68. Lee, S. E., Frenz, L. M., Wells, N. J., Johnson, A. L. and Johnston, L. H. (2001). Order of function of the budding-yeast mitotic exit-network proteins Tem1, Cdc15, Mob1, Dbf2, and Cdc5. Curr. Biol. 11, 784-788.
69. Lee, J.-H., Kim, T.-S., Yang, T.-H., Koo, B.-K., Oh, S.-P., Lee, K.-P., Oh, H.-J., Lee, S.-H., Kong, Y.-Y., Kim, J.-M. et al. (2008). A crucial role of WW45 in developing epithelial tissues in the mouse. EMBO J. 27, 1231-1242.
70. Lee, K.-P., Lee, J.-H., Kim, T.-S., Kim, T.-H., Park, H.-D., Byun, J.-S., Kim, M.-C., Jeong, W.-I., Calvisi, D.F., Kim, J.-M. et al. (2010). The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc. Natl. Acad. Sci. USA 107, 8248-8253.
71. Levy, D., Adamovich, Y., Reuven, N. and Shaul, Y. (2008). Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage. Mol. Cell 29, 350-361.
72. Li, Z., Zhao, B., Wang, P., Chen, F., Dong, Z., Yang, H., Guan, K.-L. and Xu, Y. (2010). Structural insights into the YAP and TEAD complex. Genes Dev. 24, 235-240.
73. Lian, I., Kim, J., Okazawa, H., Zhao, J., Zhao, B., Yu, J., Chinnaiyan, A., Israel, M. A., Goldstein, L. S. B., Abujarour, R. et al. (2010). The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes Dev. 24, 1106-1118.
74. Lin, Y.-T., Ding, J.-Y., Li, M.-Y., Yeh, T.-S., Wang, T.-W. and Yu, J.-Y. (2012). YAP regulates neuronal differentiation through Sonic hedgehog signaling pathway. Exp. Cell Res. 318, 1877-1888.
75. Liu, C.-Y., Zha, Z.-Y., Zhou, X., Zhang, H., Huang, W., Zhao, D., Li, T., Chan, S.W., Lim, C. J., Hong, W. et al. (2010). The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase. J. Biol. Chem. 285, 37159-37169.
76. Lorthongpanich, C., Messerschmidt, D. M., Chan, S. W., Hong, W., Knowles, B. B. and Solter, D. (2013). Temporal reduction of LATS kinases in the early preimplantation embryo prevents ICM lineage differentiation. Genes Dev. 27, 1441-1446.
77. Lu, L., Li, Y., Kim, S. M., Bossuyt, W., Liu, P., Qiu, Q., Wang, Y., Halder, G., Finegold, M. J., Lee, J.-S. et al. (2010). Hippo signaling is a potent in vivo growth and tumor suppressor pathway in themammalian liver. Proc. Natl. Acad. Sci. USA 107, 1437-1442.
78. Lutolf, M. P., Gilbert, P. M. and Blau, H. M. (2009). Designing materials to direct stem-cell fate. Nature 462, 433-441
79. Mah, A. S., Jang, J. and Deshaies, R. J.(2001). Protein kinase Cdc15 activates the Dbf2-Mob1 kinase complex. Proc. Natl. Acad. Sci. USA 98, 7325-7330.
80. Makita, R., Uchijima, Y., Nishiyama, K., Amano, T., Chen, Q., Takeuchi, T., Mitani, A., Nagase, T., Yatomi, Y., Aburatani, H. et al. (2008). Multiple renalcysts, urinary concentration defects, and pulmonary emphysematous changes in mice lacking TAZ. Am. J. Physiol. Renal Physiol. 294, F542-F553.
81. McBeath, R., Pirone, D. M., Nelson, C. M., Bhadriraju, K. and Chen, C. S. (2004). Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev. Cell 6, 483-495.
82. McClatchey, A. I., Saotome, I., Ramesh, V., Gusella, J. F. and Jacks, T. (1997). The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation. Genes Dev. 11, 1253-1265.
83. Mitani, A., Nagase, T., Fukuchi, K., Aburatani, H., Makita, R. and Kurihara, H. (2009). Transcriptional coactivator with PDZ-binding motif is essential for normal alveolarization in mice. Am. J. Respir. Crit. Care Med. 180, 326-338.
84. Mo, J.-S., Yu, F.-X., Gong, R., Brown, J. H. and Guan, K.-L. (2012). Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs). Genes Dev. 26, 2138-2143.
85. Mori, M., Triboulet, R., Mohseni, M., Schlegelmilch, K., Shrestha, K., Camargo, F. D. and Gregory, R. I. (2014). Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer. Cell 156, 893-906.
86. Morin-Kensicki, E. M., Boone, B. N., Howell, M., Stonebraker, J. R., Teed, J., Alb, J. G., Magnuson, T. R., O'Neal, W. and Milgram, S. L. (2006). Defects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation in mice with targeted disruption of Yap65. Mol. Cell. Biol. 26, 77-87.
87. Morrison, D. K. (2009). The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol. 19, 16-23.
88. Nejigane, S., Haramoto, Y., Okuno, M., Takahashi, S. and Asashima, M. (2011). The transcriptional coactivators Yap and TAZ are expressed during early Xenopus development. Int. J. Dev. Biol. 55, 121-126.
89. Nishio, M., Hamada, K., Kawahara, K., Sasaki, M., Noguchi, F., Chiba, S., Mizuno, K., Suzuki, S. O., Dong, Y., Tokuda, M. et al. (2012). Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice. J. Clin. Invest. 122, 4505-4518.
90. Nishioka, N., Yamamoto, S., Kiyonari, H., Sato, H., Sawada, A., Ota, M., Nakao, K. and Sasaki, H. (2008). Tead4 is required for specification of trophectoderm in pre-implantation mouse embryos. Mech. Dev. 125, 270-283.
91. Nishioka, N., Inoue, K.-i., Adachi, K., Kiyonari, H., Ota, M., Ralston, A., Yabuta, N., Hirahara, S., Stephenson, R. O., Ogonuki, N. et al. (2009). The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass. Dev. Cell 16, 398-410.
92. Oh, S., Lee, D., Kim, T., Kim, T.-S., Oh, H.J., Hwang, C.Y., Kong, Y.-Y., Kwon, K.-S. and Lim, D.-S. (2009). Crucial role for Mst1 and Mst2 kinases in early embryonic development of the mouse. Mol. Cell. Biol. 29, 6309-6320.
93. Oka, T. and Sudol, M. (2009). Nuclear localization and pro-apoptotic signaling of YAP2 require intact PDZ-binding motif. Genes Cells 14, 607-615.
94. Oudhoff, M. J., Freeman, S. A., Couzens, A. L., Antignano, F., Kuznetsova, E., Min, P. H., Northrop, J. P., Lehnertz, B., Barsyte-Lovejoy, D., Vedadi, M. et al. (2013). Control of the hippo pathway by Set7-dependent methylation of Yap. Dev. Cell 26, 188-194.
95. Pantalacci, S., Tapon, N. and Leopold, P. (2003). The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila. Nat. Cell Biol. 5, 921-927.
96. Paramasivam, M., Sarkeshik, A., Yates, J. R., III, Fernandes, M. J. G. and McCollum, D. (2011). Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor. Mol. Biol. Cell 22, 3725-3733.
97. Park, K.-S., Whitsett, J. A., DiPalma, T., Hong, J.-H., Yaffe, M. B. and Zannini, M. (2004). TAZ interacts with TTF-1 and regulates expression of surfactant protein-C. J. Biol. Chem. 279, 17384-17390.
98. Poon, C. L. C., Zhang, X., Lin, J. I., Manning, S. A. and Harvey, K. F. (2012). Homeodomain-interacting protein kinase regulates Hippo pathway-dependent tissue growth. Curr. Biol. 22, 1587-1594.
99. Qin, H., Blaschke, K., Wei, G., Ohi, Y., Blouin, L., Qi, Z., Yu, J., Yeh, R.-F., Hebrok, M. and Ramalho-Santos, M. (2012). Transcriptional analysis of pluripotency reveals the Hippo pathway as a barrier to reprogramming. Hum. Mol. Genet. 21, 2054-2067.
100. Reginensi, A., Scott, R. P., Gregorieff, A., Bagherie-Lachidan, M., Chung, C., Lim, D.-S., Pawson, T., Wrana, J. and McNeill, H. (2013). Yap- and Cdc42-dependent nephrogenesis and morphogenesis during mouse kidney development. PLoS Genet. 9, e1003380.
101. Remue, E., Meerschaert, K., Oka, T., Boucherie, C., Vandekerckhove, J., Sudol, M. and Gettemans, J. (2010). TAZ interacts with zonula occludens-1 and -2 proteins in a PDZ-1 dependent manner. FEBS Lett. 584, 4175-4180.
102. Rock, J. M., Lim, D., Stach, L., Ogrodowicz, R. W., Keck, J. M., Jones, M. H., Wong, C. C. L., Yates, J. R., III, Winey, M., Smerdon, S. J. et al. (2013). Activation of the yeast Hippo pathway by phosphorylation-dependent assembly of signaling complexes. Science 340, 871-875.
103. Rosenbluh, J., Nijhawan, D., Cox, A.G., Li, X., Neal, J. T., Schafer, E. J., Zack, T. I., Wang, X., Tsherniak, A., Schinzel, A. C. et al. (2012). beta-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis. Cell 151, 1457-1473.
104. Salah, Z., Alian, A. and Aqeilan, R. I. (2012). WW domain-containing proteins: retrospectives and the future. Front. Biosci. 17, 331-348.
105. Sansores-Garcia, L., Bossuyt, W., Wada, K.-I., Yonemura, S., Tao, C., Sasaki, H. and Halder, G. (2011). Modulating F-actin organization induces organ growth by affecting the Hippo pathway. EMBO J. 30, 2325-2335
106. Schlegelmilch, K., Mohseni, M., Kirak, O., Pruszak, J., Rodriguez, J. R., Zhou, D., Kreger, B. T., Vasioukhin, V., Avruch, J., Brummelkamp, T. R. et al. (2011). Yap1 acts downstream of alpha-catenin to control epidermal proliferation. Cell 144, 782-795.
107. Sebe-Pedros, A., Zheng, Y., Ruiz-Trillo, I.and Pan, D. (2012). Premetazoan origin of the hippo signaling pathway. Cell Rep. 1, 13-20.
108. Silvis, M. R., Kreger, B. T., Lien, W.-H., Klezovitch, O., Rudakova, G. M., Camargo, F. D., Lantz, D. M., Seykora, J. T. and Vasioukhin, V. (2011). alpha-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1. Sci. Signal. 4, ra33.
109. Song, H., Mak, K. K., Topol, L., Yun, K., Hu, J., Garrett, L., Chen, Y., Park, O., Chang, J., Simpson, R. M. et al. (2010). Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc. Natl. Acad. Sci. USA 107, 1431-1436.
110. Stamos, J. L. and Weis, W. I. (2013). The beta-catenin destruction complex. Cold Spring Harb. Perspect. Biol. 5, a007898.
111. Su, L. L., Ma, W. X., Yuan, J. F., Shao, Y., Xiao, W. and Jiang, S. J. (2012). Expression of Yes-associated protein in non-small cell lung cancer and its relationship with clinical pathological factors. Chin. Med. J. (Engl.) 125, 4003-4008.
112. Sudol, M. (1994). Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product. Oncogene 9, 2145-2152.
113. Sudol, M. (2013). YAP1 oncogene and its eight isoforms. Oncogene 32, 3922.
114. Sudol, M., Bork, P., Einbond, A., Kastury, K., Druck, T., Negrini, M., Huebner, K. and Lehman, D. (1995). Characterization of the mammalian YAP (Yes-associated protein) gene and its role in defining a novel protein module, the WW domain. J. Biol. Chem. 270, 14733-14741.
115. Takahashi, K. and Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676.
116. Tamm, C., Bower, N. and Anneren, C. (2011). Regulation of mouse embryonic stem cell self-renewal by a Yes-YAP-TEAD2 signaling pathway downstream of LIF. J. Cell Sci. 124, 1136-1144.
117. Tang, Y., Rowe, R. G., Botvinick, E. L., Kurup, A., Putnam, A. J., Seiki, M., Weaver, V. M., Keller, E. T., Goldstein, S., Dai, J. et al. (2013). MT1-MMP-dependent control of skeletal stem cell commitment via a beta1-integrin/YAP/TAZ signaling axis. Dev. Cell 25, 402-416.
118. Tapon, N., Harvey, K. F., Bell, D. W., Wahrer, D. C. R., Schiripo, T. A., Haber, D. A. and Hariharan, I. K. (2002). salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell 110, 467-478.
119. Tian, Y., Kolb, R., Hong, J.-H., Carroll, J., Li, D., You, J., Bronson, R., Yaffe, M. B., Zhou, J. and Benjamin, T. (2007). TAZ promotes PC2 degradation through a SCFbeta-Trcp E3 ligase complex. Mol. Cell. Biol. 27, 6383-6395.
120. Udan, R. S., Kango-Singh, M., Nolo, R., Tao, C. and Halder, G. (2003). Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway. Nat. Cell Biol. 5, 914-920.
121. Van Hateren, N. J., Das, R. M., Hautbergue, G. M., Borycki, A.-G., Placzek, M. and Wilson, S. A.(2011). FatJ acts via the Hippo mediator Yap1 torestrict the size of neural progenitor cell pools. Development 138, 1893-1902.
122. Varelas, X., Sakuma, R., Samavarchi-Tehrani, P., Peerani, R., Rao, B. M., Dembowy, J., Yaffe, M. B., Zandstra, P. W. and Wrana, J. L. (2008). TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat. Cell Biol. 10, 837-848.
123. Varelas, X., Miller, B. W., Sopko, R., Song, S., Gregorieff, A., Fellouse, F. A., Sakuma, R., Pawson, T., Hunziker, W., McNeill, H. et al. (2010a). The Hippo pathway regulates Wnt/beta-catenin signaling. Dev. Cell 18, 579-591.
124. Varelas, X., Samavarchi-Tehrani, P., Narimatsu, M., Weiss, A., Cockburn, K., Larsen, B. G., Rossant, J. and Wrana, J. L. (2010b). The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-beta-SMAD pathway. Dev. Cell 19, 831-844.
125. Wang, W., Huang, J. and Chen, J. (2011). Angiomotin-like proteins associate with and negatively regulate YAP1. J. Biol. Chem. 286, 4364-370.
126. Wang, W., Li, X., Huang, J., Feng, L., Dolinta, K. G. and Chen, J. (2013). Defining the protein-protein interaction network of the human Hippo pathway. Mol. Cell. Proteomics 13, 119-131.
127. Webb, C., Upadhyay, A., Giuntini, F., Eggleston, I., Furutani-Seiki, M., Ishima, R. and Bagby, S.(2011). Structural features and ligand binding properties oftandem WW domains from YAP and TAZ, nuclear effectors of the Hippo pathway. Biochemistry 50, 3300-3309.
128. Weiss, A. and Attisano, L. (2013). The TGFbeta superfamily signaling pathway. Wiley interdisciplinary reviews. Dev. Biol. 2, 47-63.
129. Wells, C. D., Fawcett, J.P., Traweger, A., Yamanaka, Y., Goudreault, M., Elder, K., Kulkarni, S., Gish, G., Virag, C., Lim, C. et al. (2006). A Rich1/Amot complex regulates the Cdc42 GTPase and apical-polarity proteins in epithelial cells. Cell 125, 535-548.
130. Wu, S., Huang, J., Dong, J. and Pan, D. (2003). Hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell 114, 445-456.
131. Wu, S., Liu, Y., Zheng, Y., Dong, J. and Pan, D. (2008). The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. Dev. Cell 14, 388-398.
132. Xin, M., Kim, Y., Sutherland, L. B., Qi, X., McAnally, J., Schwartz, R. J., Richardson, J. A., Bassel-Duby, R. and Olson, E. N. (2011). Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size. Sci. Signal. 4, ra70.
133. Xin, M., Kim, Y., Sutherland, L. B., Murakami, M., Qi, X., McAnally, J., Porrello, E. R., Mahmoud, A. I., Tan, W., Shelton, J. M. et al. (2013). Hippo pathway effector Yap promotes cardiac regeneration. Proc. Natl. Acad. Sci. USA 110, 13839-13844.
134. Yagi, R., Kohn, M. J., Karavanova, I., Kaneko, K. J., Vullhorst, D., DePamphilis, M. L. and Buonanno, A. (2007). Transcription factor TEAD4 specifies the trophectoderm lineage at the beginning of mammalian development. Development 134, 3827-3836.
135. Ye, F. and Zhang, M. (2013). Structures and target recognition modes of PDZ domains: recurring themes and emerging pictures. Biochem. J. 455, 1-14.
136. Yi, C., Shen, Z., Stemmer-Rachamimov, A., Dawany, N., Troutman, S., Showe, L. C., Liu, Q., Shimono, A., Sudol, M., Holmgren, L. et al. (2013). The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis. Sci. Signal. 6, ra77.
137. Yim, H., Sung, C. K., You, J., Tian, Y. and Benjamin, T. (2011). Nek1 and TAZ interact to maintain normal levels of polycystin 2. J. Am. Soc. Nephrol. 22, 832-837.
138. Yin, F., Yu, J., Zheng, Y., Chen, Q., Zhang, N. and Pan, D. (2013). Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2. Cell 154, 1342-1355.
139. Young, R. A. (2011). Control of the embryonic stem cell state. Cell 144, 940-954.
140. Yu, F.-X., Zhao, B., Panupinthu, N., Jewell, J. L., Lian, I., Wang, L. H., Zhao, J., Yuan, H., Tumaneng, K., Li, H. et al. (2012). Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 150, 780-791.
141. Yu, F.-X., Zhang, Y., Park, H. W., Jewell, J. L., Chen, Q., Deng, Y., Pan, D., Taylor, S. S., Lai, Z.-C. and Guan, K.-L. (2013). Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation. Genes Dev. 27, 1223-1232.
142. Zaidi, S. K., Sullivan, A. J., Medina, R., Ito, Y., van Wijnen, A. J., Stein, J. L., Lian, J. B. and Stein, G. S. (2004). Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription. EMBO J. 23, 790-799.
143. Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S.-T., Luk, J. M., Wigler, M., Hannon, G. J. et al. (2006). Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 125, 1253-1267.
144. Zhang, L., Ren, F., Zhang, Q., Chen, Y., Wang, B. and Jiang, J. (2008). The TEAD/ TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control. Dev. Cell 14, 377-387.
145. Zhang, H., Liu, C.-Y., Zha, Z.-Y., Zhao, B., Yao, J., Zhao, S., Xiong, Y., Lei, Q.-Y. and Guan, K.-L. (2009).TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition. J. Biol. Chem. 284, 13355-13362.
146. Zhang, N., Bai, H., David, K. K., Dong, J., Zheng, Y., Cai, J., Giovannini, M., Liu, P., Anders, R. A. and Pan, D. (2010). The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Dev. Cell 19, 27-38.
147. Zhang, H., Pasolli, H. A. and Fuchs, E. (2011). Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin. Proc. Natl. Acad. Sci. USA 108, 2270-2275.
148. Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L. et al. (2007). Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 21, 2747-2761.
149. Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M. et al. (2008). TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 22, 1962-1971.
150. Zhao, B., Li, L., Tumaneng, K., Wang, C.-Y. and Guan, K.-L. (2010).Acoordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev. 24, 72-85.
151. Zhao, B., Li, L., Lu, Q., Wang, L. H., Liu, C.-Y., Lei, Q. and Guan, K.-L. (2011). Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev. 25, 51-63.
152. Zhou, D., Conrad, C., Xia, F., Park, J.-S., Payer, B., Yin, Y., Lauwers, G. Y., Thasler, W., Lee, J. T., Avruch, J. et al. (2009). Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 16, 425-438.
153. Zhou, D., Zhang, Y., Wu, H., Barry, E., Yin, Y., Lawrence, E., Dawson, D., Willis, J. E., Markowitz, S. D., Camargo, F. D. et al. (2011a). Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc. Natl. Acad. Sci. USA 108, E1312-E1320.
154. Zhou, Z., Hao, Y., Liu, N., Raptis, L., Tsao, M.-S. and Yang, X. (2011b). TAZ is a novel oncogene in non-small cell lung cancer. Oncogene 30, 2181-2186.